On February 2nd, 2012, Virco Lab, Inc.
changed its legal name to Janssen Diagnostics, Inc.
Our website is in the process of being updated to
reflect these name changes.
Most healthcare providers understand the need to move to electronic health records (EHR). The use of paper charts may
actually impede high-quality patient care; therefore, migration to EHRs is inevitable.1,
2
The potential obstacles of transitioning from paper to electronic records can significantly impact clinical workflow, productivity, and raise concerns about privacy and confidentiality. However, the benefits and incentives of adopting EHRs are significant. Financial incentives at both the federal and state levels are available to assist the transition for a limited time. EHRs have the potential to “lessen health disparities, reduce prescription drug errors, and provide substantial cost savings by reducing wasteful spending and unnecessary duplication of services.” 3
AVIGA™ is designed as a multifunctional EHR to surmount the challenges of moving from paper to electronic systems and provide value by:
DISCLAIMER: THE INFORMATION CONTAINED IN THIS WEB SITE IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND REPRESENTS NO STATEMENT, PROMISE OR GUARANTEE BY JANSSEN DIAGNOSTICS, INC. CONCERNING RECEIPT OR PAYMENT OF GOVERNMENT INCENTIVES. JANSSEN DIAGNOSTICS, INC. STRONGLY URGES THAT YOU CONSULT WITH YOUR COUNSEL FOR ADVICE ON INCENTIVE ELIGIBILITY.
On February 2nd, 2012, Virco Lab, Inc.
changed its legal name to Janssen Diagnostics, Inc.
Our website is in the process of being updated to
reflect these name changes.
Stage 2 Meaningful Use NPRM Moves Toward Patient-Centered Care Through Wider Use of EHRs
February 28, 2012
The CMS Blog
January 19, 2012
EMR Daily News
DISCLAIMER: THE INFORMATION CONTAINED IN THIS WEB SITE IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND REPRESENTS NO STATEMENT, PROMISE OR GUARANTEE BY JANSSEN DIAGNOSTICS, INC. CONCERNING RECEIPT OR PAYMENT OF GOVERNMENT INCENTIVES. JANSSEN DIAGNOSTICS, INC. STRONGLY URGES THAT YOU CONSULT WITH YOUR COUNSEL FOR ADVICE ON INCENTIVE ELIGIBILITY.